Cancer Genetics and Epigenetics 2024, Vol.12, No.4, 210-222 http://medscipublisher.com/index.php/cge 218 Clustering and Cancer subtype identification) are being developed to effectively combine various data types, providing compact feature signatures for patient classification and improving survival endpoint predictions (Francescatto et al., 2018; Yang et al., 2022). 7.2 Integration of single-cell and spatial omics data The advent of single-cell technologies has unveiled a new dimension of cellular heterogeneity, which is crucial for understanding cancer biology. Integrating single-cell and spatial omics data can provide a comprehensive view of the tumor microenvironment and its interactions. This integration is particularly challenging due to the complexity and volume of data, but it holds the potential to uncover novel insights into cancer mechanisms and patient-specific therapeutic targets. Recent studies emphasize the importance of developing computational methods and visualization tools to handle the integration of matched and unmatched single-cell multi-omics data, which can significantly enhance our understanding of biological processes and improve cancer prediction models (Miao et al., 2021). 7.3 Real-Time data processing and prediction Real-time data processing and prediction are critical for the timely and accurate diagnosis and treatment of cancer. AI-powered systems are being developed to analyze and interpret data from various sources, including clinical, molecular, and imaging data, in real-time. For example, AI algorithms trained with multiparametric MR-US imaging data and fusion biopsy trajectory-proven pathology data have been used to predict the volume and location of clinically significant cancer, demonstrating the potential of real-time data integration for precise cancer diagnosis (Kaneko et al., 2022). Furthermore, AI-powered spatial analysis of tumor-infiltrating lymphocytes (TILs) using H&E-stained whole-slide images has shown to provide prognostic information for colon cancer in a practical and efficient manner (Lim et al., 2023). 7.4 Personalized medicine and AI Personalized medicine aims to tailor treatment strategies based on individual patient characteristics, and AI-driven multi-modal data fusion plays a pivotal role in this approach. By integrating clinical, genomic, and other omics data, AI can help identify patient-specific biomarkers and therapeutic targets, leading to more effective and personalized treatment plans. Studies have shown that combining clinical and multi-omics data can significantly improve prognostic performance for colon cancer, highlighting the potential of AI in personalized medicine (Tong et al., 2020). Additionally, AI-based systems biology approaches are being employed to analyze multi-omics data for determining cancer subtypes, disease prognosis, and therapeutic targets, further advancing the field of personalized medicine (Biswas and Chakrabarti, 2020). 7.5 Collaborative and open-source platforms The development and adoption of collaborative and open-source platforms are essential for advancing AI-driven multi-modal data fusion in cancer research. These platforms facilitate the sharing of data, tools, and methodologies among researchers, promoting transparency and reproducibility. The rise of big data and the widespread use of machine learning have led to the creation of sophisticated models that integrate clinical, molecular, and imaging data for cancer prognosis prediction (Lobato-Delgado et al., 2022). Collaborative efforts and open-source initiatives can accelerate the development of these models, enabling researchers to build on each other's work and drive innovation in the field. In conclusion, the future of AI-driven multi-modal data fusion for colon cancer prediction is promising, with emerging technologies, integration of single-cell and spatial omics data, real-time data processing, personalized medicine, and collaborative platforms paving the way for significant advancements. By leveraging these developments, researchers and clinicians can improve cancer diagnosis, prognosis, and treatment, ultimately enhancing patient outcomes. 8 Concluding Remarks The integration of multi-modal data fusion using artificial intelligence (AI) has shown significant promise in the prediction and management of colon cancer. Various studies have demonstrated the efficacy of AI in enhancing
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==